메뉴 건너뛰기




Volumn 443, Issue , 2015, Pages 17-24

Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides

Author keywords

Cardiac endocrine function; Cardiovascular risk; Heart failure; Immunoassay methods; Natriuretic peptides; Troponins

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR;

EID: 84924228354     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.06.003     Document Type: Review
Times cited : (86)

References (128)
  • 2
    • 20544453277 scopus 로고    scopus 로고
    • Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology
    • Swedberg K., Cleland J., Dargie H., et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005, 26:1115-1140.
    • (2005) Eur Heart J , vol.26 , pp. 1115-1140
    • Swedberg, K.1    Cleland, J.2    Dargie, H.3
  • 3
    • 20044379730 scopus 로고    scopus 로고
    • Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology
    • Nieminen M.S., Böhm M., Cowie M.R., et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005, 26:384-416.
    • (2005) Eur Heart J , vol.26 , pp. 384-416
    • Nieminen, M.S.1    Böhm, M.2    Cowie, M.R.3
  • 4
    • 24944563849 scopus 로고    scopus 로고
    • American College of Cardiology, American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure)
    • ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure)
    • Hunt S.A., American College of Cardiology, American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005, 46:e1-e82.
    • (2005) J Am Coll Cardiol , vol.46 , pp. e1-e82
    • Hunt, S.A.1
  • 6
    • 0034649248 scopus 로고    scopus 로고
    • Congestive heart failure: fifty years of progress
    • Braunwald E., Bristow M.R. Congestive heart failure: fifty years of progress. Circulation 2000, 102(20 Suppl. 4):IV14-IV23.
    • (2000) Circulation , vol.102 , Issue.20 , pp. IV14-IV23
    • Braunwald, E.1    Bristow, M.R.2
  • 7
    • 0032537621 scopus 로고    scopus 로고
    • Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure
    • Dipla K., Mattiello J.A., Jeevanandam V., Houser S.R., Margulies K.B. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation 1998, 97:2316-2322.
    • (1998) Circulation , vol.97 , pp. 2316-2322
    • Dipla, K.1    Mattiello, J.A.2    Jeevanandam, V.3    Houser, S.R.4    Margulies, K.B.5
  • 8
    • 0029845123 scopus 로고    scopus 로고
    • Medical therapy can improve the biologic properties of the chronically failing heart: a new era in the treatment of heart failure
    • Eichhorn E.J., Bristow M.R. Medical therapy can improve the biologic properties of the chronically failing heart: a new era in the treatment of heart failure. Circulation 1996, 94:2285-2296.
    • (1996) Circulation , vol.94 , pp. 2285-2296
    • Eichhorn, E.J.1    Bristow, M.R.2
  • 9
    • 44949196630 scopus 로고    scopus 로고
    • Cardiovascular biomarkers: increasing impact of laboratory medicine in cardiology practice
    • Vittorini S., Clerico A. Cardiovascular biomarkers: increasing impact of laboratory medicine in cardiology practice. Clin Chem Lab Med 2008, 46:748-763.
    • (2008) Clin Chem Lab Med , vol.46 , pp. 748-763
    • Vittorini, S.1    Clerico, A.2
  • 10
    • 3042706302 scopus 로고    scopus 로고
    • Role and importance of biochemical markers in clinical cardiology
    • Panteghini M. Role and importance of biochemical markers in clinical cardiology. Eur Heart J 2004, 25:1187-1196.
    • (2004) Eur Heart J , vol.25 , pp. 1187-1196
    • Panteghini, M.1
  • 12
    • 33751513756 scopus 로고    scopus 로고
    • Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart faille: a clinical review
    • De Virginy D.R. Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart faille: a clinical review. Heart Fail Rev 2006, 11:333-334.
    • (2006) Heart Fail Rev , vol.11 , pp. 333-334
    • De Virginy, D.R.1
  • 13
    • 33745004785 scopus 로고    scopus 로고
    • Biomarkers of cardiovascular disease: molecular basis and practical considerations
    • Vasan S. Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 2006, 113:2335-2362.
    • (2006) Circulation , vol.113 , pp. 2335-2362
    • Vasan, S.1
  • 15
    • 43549099569 scopus 로고    scopus 로고
    • Biomarkers in heart failure
    • Braunwald E. Biomarkers in heart failure. N Engl J Med 2008, 358:2148-2159.
    • (2008) N Engl J Med , vol.358 , pp. 2148-2159
    • Braunwald, E.1
  • 17
    • 0141995037 scopus 로고    scopus 로고
    • Cardiac natriuretic peptides: a proteomic window to cardiac function and clinical management
    • Maisel A.S., McCullough P.A. Cardiac natriuretic peptides: a proteomic window to cardiac function and clinical management. Rev Cardiovasc Med 2003, 4(Suppl. 4):S3-S12.
    • (2003) Rev Cardiovasc Med , vol.4 , pp. S3-S12
    • Maisel, A.S.1    McCullough, P.A.2
  • 18
    • 84865264018 scopus 로고    scopus 로고
    • Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care
    • Thygesen K., Mair J., Mueller C., et al. Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Eur Heart J 2012, 33:2001-2006.
    • (2012) Eur Heart J , vol.33 , pp. 2001-2006
    • Thygesen, K.1    Mair, J.2    Mueller, C.3
  • 19
    • 84884294190 scopus 로고    scopus 로고
    • 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
    • Yancy C.W., Jessup M., Bozkurt B., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013, 62:e147-e239.
    • (2013) J Am Coll Cardiol , vol.62 , pp. e147-e239
    • Yancy, C.W.1    Jessup, M.2    Bozkurt, B.3
  • 20
    • 33644795655 scopus 로고    scopus 로고
    • Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications
    • Clerico A., Recchia F.A., Passino C., Emdin M. Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications. Am J Physiol Heart Circ Physiol 2006, 290:H17-H29.
    • (2006) Am J Physiol Heart Circ Physiol , vol.290 , pp. H17-H29
    • Clerico, A.1    Recchia, F.A.2    Passino, C.3    Emdin, M.4
  • 21
    • 79959895425 scopus 로고    scopus 로고
    • Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones
    • Clerico A., Giannoni A., Vittorini S., Passino C. Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones. Am J Physiol Heart Circ Physiol 2011, 301:H12-H20.
    • (2011) Am J Physiol Heart Circ Physiol , vol.301 , pp. H12-H20
    • Clerico, A.1    Giannoni, A.2    Vittorini, S.3    Passino, C.4
  • 22
    • 69549111749 scopus 로고    scopus 로고
    • Clinical relevance of BNP measurement in the follow-up of patients with chronic heart failure
    • Clerico A., Fontana M., Ripoli A., Emdin M. Clinical relevance of BNP measurement in the follow-up of patients with chronic heart failure. Adv Clin Chem 2009, 48:163-179.
    • (2009) Adv Clin Chem , vol.48 , pp. 163-179
    • Clerico, A.1    Fontana, M.2    Ripoli, A.3    Emdin, M.4
  • 23
  • 24
    • 68849114272 scopus 로고    scopus 로고
    • Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials
    • Felker G.M., Hasselblad V., Hernandez A.F., O'Connor C.M. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials. Am Heart J 2009, 158:422-430.
    • (2009) Am Heart J , vol.158 , pp. 422-430
    • Felker, G.M.1    Hasselblad, V.2    Hernandez, A.F.3    O'Connor, C.M.4
  • 25
  • 26
    • 84902577748 scopus 로고    scopus 로고
    • Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis
    • Troughton R.W., Frampton C.M., Brunner-La Rocca H.P., et al. Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis. Eur Heart J 2014, 35:1559-1567.
    • (2014) Eur Heart J , vol.35 , pp. 1559-1567
    • Troughton, R.W.1    Frampton, C.M.2    Brunner-La Rocca, H.P.3
  • 27
    • 84873110684 scopus 로고    scopus 로고
    • Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are useful in heart failure management
    • Januzzi J.L., Troughton R. Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are useful in heart failure management. Circulation 2013, 127:500-507.
    • (2013) Circulation , vol.127 , pp. 500-507
    • Januzzi, J.L.1    Troughton, R.2
  • 28
    • 73349131123 scopus 로고    scopus 로고
    • High-sensitivity troponin: a new toll for pathophysiological investigation and clinical practice
    • Clerico A., Giannoni A., Prontera T., Giovannini S. High-sensitivity troponin: a new toll for pathophysiological investigation and clinical practice. Adv Clin Chem 2009, 49:1-30.
    • (2009) Adv Clin Chem , vol.49 , pp. 1-30
    • Clerico, A.1    Giannoni, A.2    Prontera, T.3    Giovannini, S.4
  • 29
    • 84856068587 scopus 로고    scopus 로고
    • Analytical characteristics of high-sensitivity cardiac troponin assay
    • Apple F.S., Collinson P.O. Analytical characteristics of high-sensitivity cardiac troponin assay. Clin Chem 2012, 58:54-61.
    • (2012) Clin Chem , vol.58 , pp. 54-61
    • Apple, F.S.1    Collinson, P.O.2
  • 30
    • 0041431119 scopus 로고    scopus 로고
    • Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure
    • Horwich T.B., Patel J., MacLellan W.R., et al. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 2003, 108:833-838.
    • (2003) Circulation , vol.108 , pp. 833-838
    • Horwich, T.B.1    Patel, J.2    MacLellan, W.R.3
  • 31
    • 0035936510 scopus 로고    scopus 로고
    • Persistently increased serum concentrations of cardiac troponin t in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes
    • Sato Y., Yamada T., Taniguchi R., et al. Persistently increased serum concentrations of cardiac troponin t in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation 2001, 103:369-374.
    • (2001) Circulation , vol.103 , pp. 369-374
    • Sato, Y.1    Yamada, T.2    Taniguchi, R.3
  • 32
    • 0032842145 scopus 로고    scopus 로고
    • Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure
    • [A9]
    • Setsuta K., Seino Y., Takahashi N., et al. Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure. Am J Cardiol 1999, 84:608-611. [A9].
    • (1999) Am J Cardiol , vol.84 , pp. 608-611
    • Setsuta, K.1    Seino, Y.2    Takahashi, N.3
  • 33
    • 2342440919 scopus 로고    scopus 로고
    • Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis
    • Hudson M.P., O'Connor C.M., Gattis W.A., et al. Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis. Am Heart J 2004, 147:546-552.
    • (2004) Am Heart J , vol.147 , pp. 546-552
    • Hudson, M.P.1    O'Connor, C.M.2    Gattis, W.A.3
  • 34
    • 37549061014 scopus 로고    scopus 로고
    • Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE
    • Fonarow G.C., Peacock W.F., Horwich T.B., et al. Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE. Am J Cardiol 2008, 101:231-237.
    • (2008) Am J Cardiol , vol.101 , pp. 231-237
    • Fonarow, G.C.1    Peacock, W.F.2    Horwich, T.B.3
  • 35
    • 43549083514 scopus 로고    scopus 로고
    • Cardiac troponin and outcome in acute heart failure
    • Peacock W.F.I.V., De Marco T., Fonarow G.C., et al. Cardiac troponin and outcome in acute heart failure. N Engl J Med 2008, 358:2117-2126.
    • (2008) N Engl J Med , vol.358 , pp. 2117-2126
    • Peacock, W.F.I.V.1    De Marco, T.2    Fonarow, G.C.3
  • 36
    • 46849116888 scopus 로고    scopus 로고
    • Clinical significance of cardiac troponins I and T in acute heart failure
    • Ilva T., Lassus J., Siirila-Waris K., et al. Clinical significance of cardiac troponins I and T in acute heart failure. Eur J Heart Fail 2008, 10:772-779.
    • (2008) Eur J Heart Fail , vol.10 , pp. 772-779
    • Ilva, T.1    Lassus, J.2    Siirila-Waris, K.3
  • 37
    • 0030723975 scopus 로고    scopus 로고
    • Circulating cardiac troponin I in severe congestive heart failure
    • Missov E., Calzolari C., Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation 1997, 96:2953-2958.
    • (1997) Circulation , vol.96 , pp. 2953-2958
    • Missov, E.1    Calzolari, C.2    Pau, B.3
  • 38
    • 84873412696 scopus 로고    scopus 로고
    • Recurrent low-level troponin I elevation is a worse prognostic indicator than occasional injury pattern in patients hospitalized with heart failure
    • Ather S., Hira R.S., Shenoy M., et al. Recurrent low-level troponin I elevation is a worse prognostic indicator than occasional injury pattern in patients hospitalized with heart failure. Int J Cardiol 2011, 301:H2351-H2361.
    • (2011) Int J Cardiol , vol.301 , pp. H2351-H2361
    • Ather, S.1    Hira, R.S.2    Shenoy, M.3
  • 39
    • 84866400461 scopus 로고    scopus 로고
    • Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: heart failure section
    • Januzzi J.L., Filippatos G., Nieminen M., et al. Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: heart failure section. Eur Heart J 2012, 33:2265-2271.
    • (2012) Eur Heart J , vol.33 , pp. 2265-2271
    • Januzzi, J.L.1    Filippatos, G.2    Nieminen, M.3
  • 40
    • 79960350455 scopus 로고    scopus 로고
    • Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival
    • Tang W.H., Shrestha K., Shao Z., et al. Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival. Am J Cardiol 2011, 108:385-390.
    • (2011) Am J Cardiol , vol.108 , pp. 385-390
    • Tang, W.H.1    Shrestha, K.2    Shao, Z.3
  • 41
    • 78651387589 scopus 로고    scopus 로고
    • Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
    • de Boer R.A., Lok D.J., Jaarsma T., et al. Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction. Ann Med 2011, 43:60-68.
    • (2011) Ann Med , vol.43 , pp. 60-68
    • de Boer, R.A.1    Lok, D.J.2    Jaarsma, T.3
  • 42
    • 77954658143 scopus 로고    scopus 로고
    • Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study
    • Lok D.J., van der Meer P., de la Porte P.W., et al. Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study. Clin Res Cardiol 2010, 99:323-328.
    • (2010) Clin Res Cardiol , vol.99 , pp. 323-328
    • Lok, D.J.1    van der Meer, P.2    de la Porte, P.W.3
  • 43
    • 77955463871 scopus 로고    scopus 로고
    • Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure
    • Shah R.V., Chen-Tournoux A.A., Picard M.H., et al. Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure. Eur J Heart Fail 2010, 12:826-832.
    • (2010) Eur J Heart Fail , vol.12 , pp. 826-832
    • Shah, R.V.1    Chen-Tournoux, A.A.2    Picard, M.H.3
  • 44
    • 84859639923 scopus 로고    scopus 로고
    • Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study
    • Felker G.M., Fiuzat M., Shaw L.K., et al. Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study. Circ Heart Fail 2012, 5:72-78.
    • (2012) Circ Heart Fail , vol.5 , pp. 72-78
    • Felker, G.M.1    Fiuzat, M.2    Shaw, L.K.3
  • 45
    • 84870482586 scopus 로고    scopus 로고
    • Galectin 3 complements BNP in risk stratification in acute heart failure
    • Fermann G.J., Lindsell C.J., Storrow A.B., et al. Galectin 3 complements BNP in risk stratification in acute heart failure. Biomarkers 2012, 17:706-713.
    • (2012) Biomarkers , vol.17 , pp. 706-713
    • Fermann, G.J.1    Lindsell, C.J.2    Storrow, A.B.3
  • 46
    • 84555204713 scopus 로고    scopus 로고
    • Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial
    • Lopez-Andrès N., Rossignol P., Iraqi W., et al. Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial. Eur J Heart Fail 2012, 14:74-81.
    • (2012) Eur J Heart Fail , vol.14 , pp. 74-81
    • Lopez-Andrès, N.1    Rossignol, P.2    Iraqi, W.3
  • 47
    • 84877106997 scopus 로고    scopus 로고
    • Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT
    • Anand I.S., Rector T.S., Kuskowski M., et al. Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT. Eur J Heart Fail 2013, 15:511-518.
    • (2013) Eur J Heart Fail , vol.15 , pp. 511-518
    • Anand, I.S.1    Rector, T.S.2    Kuskowski, M.3
  • 48
    • 84887625229 scopus 로고    scopus 로고
    • Predictive value of serum galectin-3 levels in patients with acute heart failure with preserved ejection fraction
    • Carrasco-Sánchez F.J., Aramburu-Bodas O., Salamanca-Bautista P., et al. Predictive value of serum galectin-3 levels in patients with acute heart failure with preserved ejection fraction. Int J Cardiol 2013, 169:177-182.
    • (2013) Int J Cardiol , vol.169 , pp. 177-182
    • Carrasco-Sánchez, F.J.1    Aramburu-Bodas, O.2    Salamanca-Bautista, P.3
  • 49
    • 84878544017 scopus 로고    scopus 로고
    • Predictive value of plasma galectin-3 in patients with chronic heart failure
    • Chen K., Jiang R.J., Wang C.Q., et al. Predictive value of plasma galectin-3 in patients with chronic heart failure. Eur Rev Med Pharmacol Sci 2013, 17:1005-1011.
    • (2013) Eur Rev Med Pharmacol Sci , vol.17 , pp. 1005-1011
    • Chen, K.1    Jiang, R.J.2    Wang, C.Q.3
  • 51
    • 84886698796 scopus 로고    scopus 로고
    • Incremental prognostic power of novel biomarkers (growth-differentiation factor-15, high-sensitivity C-reactive protein, galectin-3, and high-sensitivity troponin-T) in patients with advanced chronic heart failure
    • Lok D.J., Klip I.T., Lok S.I., et al. Incremental prognostic power of novel biomarkers (growth-differentiation factor-15, high-sensitivity C-reactive protein, galectin-3, and high-sensitivity troponin-T) in patients with advanced chronic heart failure. Am J Cardiol 2013, 112:831-837.
    • (2013) Am J Cardiol , vol.112 , pp. 831-837
    • Lok, D.J.1    Klip, I.T.2    Lok, S.I.3
  • 52
    • 84885044150 scopus 로고    scopus 로고
    • Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study
    • Motiwala S.R., Szymonifka J., Belcher A., et al. Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study. Eur J Heart Fail 2013, 15:1157-1163.
    • (2013) Eur J Heart Fail , vol.15 , pp. 1157-1163
    • Motiwala, S.R.1    Szymonifka, J.2    Belcher, A.3
  • 53
    • 84877246724 scopus 로고    scopus 로고
    • Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH
    • van der Velde A.R., Gullestad L., Ueland T., et al. Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH. Circ Heart Fail 2013, 6:219-226.
    • (2013) Circ Heart Fail , vol.6 , pp. 219-226
    • van der Velde, A.R.1    Gullestad, L.2    Ueland, T.3
  • 54
    • 34547582106 scopus 로고    scopus 로고
    • Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study
    • Januzzi J.L., Peacock W.F., Maisel A.S., et al. Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study. J Am Coll Cardiol 2007, 50:607-613.
    • (2007) J Am Coll Cardiol , vol.50 , pp. 607-613
    • Januzzi, J.L.1    Peacock, W.F.2    Maisel, A.S.3
  • 55
    • 42449133778 scopus 로고    scopus 로고
    • Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure
    • Mueller T., Dieplinger B., Gegenhuber A., Poelz W., Pacher R., Haltmayer M. Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure. Clin Chem 2008, 54:752-756.
    • (2008) Clin Chem , vol.54 , pp. 752-756
    • Mueller, T.1    Dieplinger, B.2    Gegenhuber, A.3    Poelz, W.4    Pacher, R.5    Haltmayer, M.6
  • 56
    • 53949108120 scopus 로고    scopus 로고
    • Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure
    • Rehman S.U., Mueller T., Januzzi J.L. Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure. J Am Coll Cardiol 2008, 52:1458-1465.
    • (2008) J Am Coll Cardiol , vol.52 , pp. 1458-1465
    • Rehman, S.U.1    Mueller, T.2    Januzzi, J.L.3
  • 57
    • 78650868251 scopus 로고    scopus 로고
    • Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction
    • Manzano-Fernandez S., Mueller T., Pascual-Figal D., et al. Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction. Am J Cardiol 2011, 107:259-267.
    • (2011) Am J Cardiol , vol.107 , pp. 259-267
    • Manzano-Fernandez, S.1    Mueller, T.2    Pascual-Figal, D.3
  • 58
    • 84859219085 scopus 로고    scopus 로고
    • ST2 has diagnostic and prognostic utility for all-cause mortality and heart failure in patients presenting to the emergency department with chest pain
    • Aldous S.J., Richards A.M., Troughton R., Than M. ST2 has diagnostic and prognostic utility for all-cause mortality and heart failure in patients presenting to the emergency department with chest pain. J Card Fail 2012, 18:304-310.
    • (2012) J Card Fail , vol.18 , pp. 304-310
    • Aldous, S.J.1    Richards, A.M.2    Troughton, R.3    Than, M.4
  • 59
    • 84860675846 scopus 로고    scopus 로고
    • Soluble ST2 as a diagnostic and prognostic marker for acute heart failure syndromes
    • Henry-Okafor Q., Collins S.P., Jenkins C.A., et al. Soluble ST2 as a diagnostic and prognostic marker for acute heart failure syndromes. Open Biomark J 2012, 2012:1-8.
    • (2012) Open Biomark J , vol.2012 , pp. 1-8
    • Henry-Okafor, Q.1    Collins, S.P.2    Jenkins, C.A.3
  • 60
    • 84888056391 scopus 로고    scopus 로고
    • Soluble ST2 serum concentration and renal function in heart failure
    • Bayes-Genis A., Zamora E., de Antonio M., et al. Soluble ST2 serum concentration and renal function in heart failure. J Card Fail 2013, 19:768-775.
    • (2013) J Card Fail , vol.19 , pp. 768-775
    • Bayes-Genis, A.1    Zamora, E.2    de Antonio, M.3
  • 61
    • 84890253068 scopus 로고    scopus 로고
    • Heart failure therapy-induced early ST2 changes may offer long-term therapy guidance
    • Breidthardt T., Balmelli C., Twerenbold R., et al. Heart failure therapy-induced early ST2 changes may offer long-term therapy guidance. J Card Fail 2013, 19:821-828.
    • (2013) J Card Fail , vol.19 , pp. 821-828
    • Breidthardt, T.1    Balmelli, C.2    Twerenbold, R.3
  • 62
    • 84874610413 scopus 로고    scopus 로고
    • Soluble ST2 is associated with all-cause and cardiovascular mortality in a population-based cohort: the Dallas Heart Study
    • Chen L.Q., de Lemos J.A., Das S.R., Ayers C.R., Rohatgi A. Soluble ST2 is associated with all-cause and cardiovascular mortality in a population-based cohort: the Dallas Heart Study. Clin Chem 2013, 59:536-546.
    • (2013) Clin Chem , vol.59 , pp. 536-546
    • Chen, L.Q.1    de Lemos, J.A.2    Das, S.R.3    Ayers, C.R.4    Rohatgi, A.5
  • 63
    • 84875173419 scopus 로고    scopus 로고
    • Soluble ST2 as a biomarker for detecting stable heart failure with a normal ejection fraction in hypertensive patients
    • Wang Y.C., Yu C.C., Chiu F.C., et al. Soluble ST2 as a biomarker for detecting stable heart failure with a normal ejection fraction in hypertensive patients. J Card Fail 2013, 19:163-168.
    • (2013) J Card Fail , vol.19 , pp. 163-168
    • Wang, Y.C.1    Yu, C.C.2    Chiu, F.C.3
  • 64
    • 84894070849 scopus 로고    scopus 로고
    • Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction
    • Gruson D., Lepoutre T., Ahn S.A., Rousseau M.F. Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction. Int J Cardiol 2014, 172:e250-e252.
    • (2014) Int J Cardiol , vol.172 , pp. e250-e252
    • Gruson, D.1    Lepoutre, T.2    Ahn, S.A.3    Rousseau, M.F.4
  • 65
    • 1042301961 scopus 로고    scopus 로고
    • Evaluating a new marker's predictive contribution
    • Kattan M.W. Evaluating a new marker's predictive contribution. Clin Cancer Res 2004, 10:822-824.
    • (2004) Clin Cancer Res , vol.10 , pp. 822-824
    • Kattan, M.W.1
  • 66
    • 0037154285 scopus 로고    scopus 로고
    • Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study
    • Assmann G., Cullen P., Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002, 105:310-315.
    • (2002) Circulation , vol.105 , pp. 310-315
    • Assmann, G.1    Cullen, P.2    Schulte, H.3
  • 67
    • 0038579421 scopus 로고    scopus 로고
    • Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
    • Conroy R.M., Pyorala K., Fitzgerald A.P., et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003, 24:987-1003.
    • (2003) Eur Heart J , vol.24 , pp. 987-1003
    • Conroy, R.M.1    Pyorala, K.2    Fitzgerald, A.P.3
  • 68
    • 2342516164 scopus 로고    scopus 로고
    • Observations, predictions and decisions - assessing cardiovascular risk assessment
    • Hense H.W. Observations, predictions and decisions - assessing cardiovascular risk assessment. Int J Epidemiol 2004, 33:235-239.
    • (2004) Int J Epidemiol , vol.33 , pp. 235-239
    • Hense, H.W.1
  • 69
    • 66349111734 scopus 로고    scopus 로고
    • Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association
    • Hlatky M.A., Greenland P., Arnett D.K., et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 2009, 119:2408-2416.
    • (2009) Circulation , vol.119 , pp. 2408-2416
    • Hlatky, M.A.1    Greenland, P.2    Arnett, D.K.3
  • 72
    • 79951587253 scopus 로고    scopus 로고
    • Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction
    • Wang T.J. Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction. Circulation 2011, 123:551-565.
    • (2011) Circulation , vol.123 , pp. 551-565
    • Wang, T.J.1
  • 74
    • 0042474263 scopus 로고    scopus 로고
    • The increasing impact of laboratory medicine on clinical cardiology
    • Clerico A. The increasing impact of laboratory medicine on clinical cardiology. Clin Chem Lab Med 2003, 41:871-883.
    • (2003) Clin Chem Lab Med , vol.41 , pp. 871-883
    • Clerico, A.1
  • 75
    • 33645791709 scopus 로고    scopus 로고
    • Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay
    • Clerico A., Zucchelli G.C., Pilo A., Passino C., Emdin M. Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay. Clin Chem Lab Med 2006, 44:366-378.
    • (2006) Clin Chem Lab Med , vol.44 , pp. 366-378
    • Clerico, A.1    Zucchelli, G.C.2    Pilo, A.3    Passino, C.4    Emdin, M.5
  • 76
    • 44949146084 scopus 로고    scopus 로고
    • Distribution of plasma cardiac troponin I values in healthy subjects: pathophysiological considerations
    • Clerico A., Fortunato A., Ripoli A., Prontera C., Zucchelli G.C., Emdin M. Distribution of plasma cardiac troponin I values in healthy subjects: pathophysiological considerations. Clin Chem Lab Med 2008, 46:804-808.
    • (2008) Clin Chem Lab Med , vol.46 , pp. 804-808
    • Clerico, A.1    Fortunato, A.2    Ripoli, A.3    Prontera, C.4    Zucchelli, G.C.5    Emdin, M.6
  • 77
    • 77952498617 scopus 로고    scopus 로고
    • Reference intervals for brain natriuretic peptide in healthy newborns and infants measured with an automated immunoassay platform
    • Cantinotti M., Storti S., Parri M.S., Prontera C., Murzi B., Clerico A. Reference intervals for brain natriuretic peptide in healthy newborns and infants measured with an automated immunoassay platform. Clin Chem Lab Med 2010, 48:697-700.
    • (2010) Clin Chem Lab Med , vol.48 , pp. 697-700
    • Cantinotti, M.1    Storti, S.2    Parri, M.S.3    Prontera, C.4    Murzi, B.5    Clerico, A.6
  • 78
    • 70349802010 scopus 로고    scopus 로고
    • Measurement of circulating concentrations of cardiac troponin I and T in healthy subjects: a tool for monitoring myocardial tissue renewal?
    • Giannoni A., Giovannini S., Clerico A. Measurement of circulating concentrations of cardiac troponin I and T in healthy subjects: a tool for monitoring myocardial tissue renewal?. Clin Chem Lab Med 2009, 47:1167-1177.
    • (2009) Clin Chem Lab Med , vol.47 , pp. 1167-1177
    • Giannoni, A.1    Giovannini, S.2    Clerico, A.3
  • 79
    • 40449126121 scopus 로고    scopus 로고
    • Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage
    • Luckenbill K.N., Christenson R.H., Jaffe A.S., et al. Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage. Clin Chem 2008, 54:619-621.
    • (2008) Clin Chem , vol.54 , pp. 619-621
    • Luckenbill, K.N.1    Christenson, R.H.2    Jaffe, A.S.3
  • 80
    • 84856554908 scopus 로고    scopus 로고
    • Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance
    • Clerico A., Vittorini S., Passino C. Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance. Clin Chem Lab Med 2011, 4:1949-1954.
    • (2011) Clin Chem Lab Med , vol.4 , pp. 1949-1954
    • Clerico, A.1    Vittorini, S.2    Passino, C.3
  • 81
    • 77950280653 scopus 로고    scopus 로고
    • Biosynthesis of cardiac natriuretic peptides
    • Goetze J.P. Biosynthesis of cardiac natriuretic peptides. Results Probl Cell Differ 2010, 50:97-120.
    • (2010) Results Probl Cell Differ , vol.50 , pp. 97-120
    • Goetze, J.P.1
  • 82
    • 7844241913 scopus 로고    scopus 로고
    • Degradation of cardiac troponin I: implication for reliable immunodetection
    • Katrukha A.G., Bereznikova A.V., Filatov V.L., et al. Degradation of cardiac troponin I: implication for reliable immunodetection. Clin Chem 1998, 44:2433-2440.
    • (1998) Clin Chem , vol.44 , pp. 2433-2440
    • Katrukha, A.G.1    Bereznikova, A.V.2    Filatov, V.L.3
  • 83
    • 60749093017 scopus 로고    scopus 로고
    • Assay-related issues in the measurement of cardiac troponins
    • Panteghini M. Assay-related issues in the measurement of cardiac troponins. Clin Chim Acta 2009, 402:88-93.
    • (2009) Clin Chim Acta , vol.402 , pp. 88-93
    • Panteghini, M.1
  • 84
    • 77954774602 scopus 로고    scopus 로고
    • Standardisation of cardiac troponin I measurement: past and present
    • Tate J.R., Bunk D.M., Christenson R.H., et al. Standardisation of cardiac troponin I measurement: past and present. Pathology 2010, 42:402-408.
    • (2010) Pathology , vol.42 , pp. 402-408
    • Tate, J.R.1    Bunk, D.M.2    Christenson, R.H.3
  • 85
    • 0742304262 scopus 로고    scopus 로고
    • Evaluation of imprecision for cardiac troponin assays at low-range concentrations
    • Panteghini M., Pagani F., Yeo K.T., et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 2004, 50:327-332.
    • (2004) Clin Chem , vol.50 , pp. 327-332
    • Panteghini, M.1    Pagani, F.2    Yeo, K.T.3
  • 86
    • 0033775410 scopus 로고    scopus 로고
    • Measurement of natriuretic cardiac hormones (ANP, BNP, and related peptides) in clinical practice: the need for a new generation of immunoassay methods
    • Clerico A., Del Ry S., Giannessi D. Measurement of natriuretic cardiac hormones (ANP, BNP, and related peptides) in clinical practice: the need for a new generation of immunoassay methods. Clin Chem 2000, 46:1529-1534.
    • (2000) Clin Chem , vol.46 , pp. 1529-1534
    • Clerico, A.1    Del Ry, S.2    Giannessi, D.3
  • 87
    • 14644431817 scopus 로고    scopus 로고
    • Performance characteristics of four automated natriuretic peptide assays
    • Rawlins M.L., Owen W.E., Roberts W.L. Performance characteristics of four automated natriuretic peptide assays. Am J Clin Pathol 2005, 123:439-445.
    • (2005) Am J Clin Pathol , vol.123 , pp. 439-445
    • Rawlins, M.L.1    Owen, W.E.2    Roberts, W.L.3
  • 88
    • 14544292879 scopus 로고    scopus 로고
    • Quality specifications for B-type natriuretic peptide assays
    • Apple F.S., Panteghini M., Ravkilde J., et al. Quality specifications for B-type natriuretic peptide assays. Clin Chem 2005, 51:486-493.
    • (2005) Clin Chem , vol.51 , pp. 486-493
    • Apple, F.S.1    Panteghini, M.2    Ravkilde, J.3
  • 89
    • 34548404811 scopus 로고    scopus 로고
    • National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: analytical issues for biomarkers of heart failure
    • Apple F.S., Wu A.H., Jaffe A.S., et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: analytical issues for biomarkers of heart failure. Circulation 2007, 116:e95-e98.
    • (2007) Circulation , vol.116 , pp. e95-e98
    • Apple, F.S.1    Wu, A.H.2    Jaffe, A.S.3
  • 90
    • 67650637716 scopus 로고    scopus 로고
    • Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmoCheck study
    • Prontera C., Zaninotto M., Giovannini S., et al. Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmoCheck study. Clin Chem Lab Med 2009, 47:762-768.
    • (2009) Clin Chem Lab Med , vol.47 , pp. 762-768
    • Prontera, C.1    Zaninotto, M.2    Giovannini, S.3
  • 91
    • 84866481231 scopus 로고    scopus 로고
    • State of the art of BNP and NT-proBNP immunoassays: the CardioOrmoCheck study
    • Clerico A., Zaninotto M., Prontera C., et al. State of the art of BNP and NT-proBNP immunoassays: the CardioOrmoCheck study. Clin Chim Acta 2012, 414:112-119.
    • (2012) Clin Chim Acta , vol.414 , pp. 112-119
    • Clerico, A.1    Zaninotto, M.2    Prontera, C.3
  • 92
    • 0031800740 scopus 로고    scopus 로고
    • Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I
    • Wu A.H.B., Feng Y.J., Moore R., et al. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. Clin Chem 1998, 44:1198-1208.
    • (1998) Clin Chem , vol.44 , pp. 1198-1208
    • Wu, A.H.B.1    Feng, Y.J.2    Moore, R.3
  • 93
    • 84856074170 scopus 로고    scopus 로고
    • Standardization of cardiac troponin I assays will not occur in my lifetime
    • Apple F.S. Standardization of cardiac troponin I assays will not occur in my lifetime. Clin Chem 2012, 58:169-171.
    • (2012) Clin Chem , vol.58 , pp. 169-171
    • Apple, F.S.1
  • 94
    • 0035102976 scopus 로고    scopus 로고
    • Standardization of cardiac troponin I assays: round robin of ten candidate reference materials
    • Christenson R.H., Duh S.H., Apple F.S., et al. Standardization of cardiac troponin I assays: round robin of ten candidate reference materials. Clin Chem 2001, 47:431-437.
    • (2001) Clin Chem , vol.47 , pp. 431-437
    • Christenson, R.H.1    Duh, S.H.2    Apple, F.S.3
  • 95
    • 84856075410 scopus 로고    scopus 로고
    • IFCC Working Group on Standardization of Troponin I Point: put simply, standardization of cardiac troponin I is complicated
    • Christenson R.H., Bunk D.M., Schimmel H., Tate J.R., IFCC Working Group on Standardization of Troponin I Point: put simply, standardization of cardiac troponin I is complicated. Clin Chem 2012, 58:165-168.
    • (2012) Clin Chem , vol.58 , pp. 165-168
    • Christenson, R.H.1    Bunk, D.M.2    Schimmel, H.3    Tate, J.R.4
  • 96
    • 84872388578 scopus 로고    scopus 로고
    • Harmonization of measurement procedures: how do we get it done?
    • Gantzer M.L., Miller W.G. Harmonization of measurement procedures: how do we get it done?. Clin Biochem Rev 2012, 33:95-100.
    • (2012) Clin Biochem Rev , vol.33 , pp. 95-100
    • Gantzer, M.L.1    Miller, W.G.2
  • 97
    • 79953127847 scopus 로고    scopus 로고
    • Harmonization of free thyroid hormone test: a mission impossible?
    • Iervasi G., Clerico A. Harmonization of free thyroid hormone test: a mission impossible?. Clin Chem Lab Med 2011, 49:43-48.
    • (2011) Clin Chem Lab Med , vol.49 , pp. 43-48
    • Iervasi, G.1    Clerico, A.2
  • 98
    • 33847358624 scopus 로고    scopus 로고
    • Evidence for functional heterogeneity of circulating B-type natriuretic peptide
    • Liang F., O'Rear J., Schellenberger U., et al. Evidence for functional heterogeneity of circulating B-type natriuretic peptide. J Am Coll Cardiol 2007, 49:1071-1078.
    • (2007) J Am Coll Cardiol , vol.49 , pp. 1071-1078
    • Liang, F.1    O'Rear, J.2    Schellenberger, U.3
  • 99
    • 4344588833 scopus 로고    scopus 로고
    • Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited
    • Goetze J.P. Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited. Clin Chem 2004, 49:1503-1510.
    • (2004) Clin Chem , vol.49 , pp. 1503-1510
    • Goetze, J.P.1
  • 100
    • 4043094879 scopus 로고    scopus 로고
    • ProBNP-derived peptides in cardiac disease
    • Goetze J.P. ProBNP-derived peptides in cardiac disease. Scand J Clin Lab Invest 2004, 64:497-510.
    • (2004) Scand J Clin Lab Invest , vol.64 , pp. 497-510
    • Goetze, J.P.1
  • 101
    • 33646916875 scopus 로고    scopus 로고
    • Assay for measurement of intact B-type natriuretic peptide prohormone in blood
    • Giuliani I., Rieunier F., Larue C., et al. Assay for measurement of intact B-type natriuretic peptide prohormone in blood. Clin Chem 2006, 52:1054-1061.
    • (2006) Clin Chem , vol.52 , pp. 1054-1061
    • Giuliani, I.1    Rieunier, F.2    Larue, C.3
  • 102
    • 34248336125 scopus 로고    scopus 로고
    • The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure
    • Seferian K.R., Tamm N.N., Semenov A.G., et al. The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure. Clin Chem 2007, 53:866-873.
    • (2007) Clin Chem , vol.53 , pp. 866-873
    • Seferian, K.R.1    Tamm, N.N.2    Semenov, A.G.3
  • 103
    • 43449109489 scopus 로고    scopus 로고
    • Analysis of circulating forms of proBNP and NT-proBNP in patients with severe heart failure
    • Hammerer-Lercher A., Halfinger B., Sarg B., et al. Analysis of circulating forms of proBNP and NT-proBNP in patients with severe heart failure. Clin Chem 2008, 54:858-865.
    • (2008) Clin Chem , vol.54 , pp. 858-865
    • Hammerer-Lercher, A.1    Halfinger, B.2    Sarg, B.3
  • 104
    • 70549085028 scopus 로고    scopus 로고
    • Peptide hormones and their prohormones as biomarkers
    • Goetze J.P., Rehfeld J.F. Peptide hormones and their prohormones as biomarkers. Biomark Med 2009, 3:335-338.
    • (2009) Biomark Med , vol.3 , pp. 335-338
    • Goetze, J.P.1    Rehfeld, J.F.2
  • 105
    • 77951900236 scopus 로고    scopus 로고
    • Simultaneous assessment of unprocessed ProBNP 1-108 in addition to processed BNP32 improves risk stratification in ambulatory patients with systolic heart failure
    • Dries D.J., Ky B., Wu A., Rame J.E., Putt M., Cappola T. Simultaneous assessment of unprocessed ProBNP 1-108 in addition to processed BNP32 improves risk stratification in ambulatory patients with systolic heart failure. Circ Heart Fail 2010, 3:220-227.
    • (2010) Circ Heart Fail , vol.3 , pp. 220-227
    • Dries, D.J.1    Ky, B.2    Wu, A.3    Rame, J.E.4    Putt, M.5    Cappola, T.6
  • 106
    • 0041467795 scopus 로고    scopus 로고
    • The paradox of increased natriuretic hormones in congestive heart failure patients: does the endocrine heart also fail in heart failure?
    • Goetze J.P., Kastrup J., Rehfeld J.F. The paradox of increased natriuretic hormones in congestive heart failure patients: does the endocrine heart also fail in heart failure?. Eur Heart J 2003, 24:1471-1472.
    • (2003) Eur Heart J , vol.24 , pp. 1471-1472
    • Goetze, J.P.1    Kastrup, J.2    Rehfeld, J.F.3
  • 107
    • 0036092948 scopus 로고    scopus 로고
    • Quantification of pro-B-type natriuretic peptide and its products in human plasma by use of an analysis independent of precursor processing
    • Goetze J.P., Kastrup J., Pedersen F., Rehfeld J.F. Quantification of pro-B-type natriuretic peptide and its products in human plasma by use of an analysis independent of precursor processing. Clin Chem 2002, 48:1035-1042.
    • (2002) Clin Chem , vol.48 , pp. 1035-1042
    • Goetze, J.P.1    Kastrup, J.2    Pedersen, F.3    Rehfeld, J.F.4
  • 108
    • 79952661776 scopus 로고    scopus 로고
    • Pro-B-type natriuretic peptide 1-108 circulates in the general community: plasma determinants and detection of left ventricular systolic dysfunction
    • Macheret F., Boerrigter G., McKie P., et al. Pro-B-type natriuretic peptide 1-108 circulates in the general community: plasma determinants and detection of left ventricular systolic dysfunction. J Am Coll Cardiol 2011, 57:1386-1395.
    • (2011) J Am Coll Cardiol , vol.57 , pp. 1386-1395
    • Macheret, F.1    Boerrigter, G.2    McKie, P.3
  • 109
    • 0036136991 scopus 로고    scopus 로고
    • Molecular forms of human brain natriuretic peptide in plasma
    • Shimizu H., Masuta K., Aono K., et al. Molecular forms of human brain natriuretic peptide in plasma. Clin Chim Acta 2002, 316:129-135.
    • (2002) Clin Chim Acta , vol.316 , pp. 129-135
    • Shimizu, H.1    Masuta, K.2    Aono, K.3
  • 110
    • 12444278136 scopus 로고    scopus 로고
    • Characterization of molecular forms of probrain natriuretic peptide in human plasma
    • Shimizu H., Masuta K., Asada H., Sugita K., Sairenji T. Characterization of molecular forms of probrain natriuretic peptide in human plasma. Clin Chim Acta 2003, 334:233-239.
    • (2003) Clin Chim Acta , vol.334 , pp. 233-239
    • Shimizu, H.1    Masuta, K.2    Asada, H.3    Sugita, K.4    Sairenji, T.5
  • 112
    • 43449117210 scopus 로고    scopus 로고
    • Immunodetection of glycosylated NT-proBNP circulating in human blood
    • Seferian K.R., Tamm N.N., Semenov A.G., et al. Immunodetection of glycosylated NT-proBNP circulating in human blood. Clin Chem 2008, 54:866-873.
    • (2008) Clin Chem , vol.54 , pp. 866-873
    • Seferian, K.R.1    Tamm, N.N.2    Semenov, A.G.3
  • 113
    • 44949096268 scopus 로고    scopus 로고
    • A glycosylated form of the human cardiac hormone pro B-type natriuretic peptide is an intrinsically unstructured monomeric protein
    • Crimmins D.L., Kao J.L. A glycosylated form of the human cardiac hormone pro B-type natriuretic peptide is an intrinsically unstructured monomeric protein. Arch Biochem Biophys 2008, 475:36-41.
    • (2008) Arch Biochem Biophys , vol.475 , pp. 36-41
    • Crimmins, D.L.1    Kao, J.L.2
  • 114
    • 62149147584 scopus 로고    scopus 로고
    • Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site
    • Semenov A.G., Postnikov A.B., Tamm N.N., et al. Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site. Clin Chem 2009, 55:489-498.
    • (2009) Clin Chem , vol.55 , pp. 489-498
    • Semenov, A.G.1    Postnikov, A.B.2    Tamm, N.N.3
  • 115
    • 79960584348 scopus 로고    scopus 로고
    • Comparison of mass spectrometry and clinical assay measurements of circulating fragments of B-type natriuretic peptide in patients with chronic heart failure
    • Miller W.L., Phelps M.A., Wood C.M., et al. Comparison of mass spectrometry and clinical assay measurements of circulating fragments of B-type natriuretic peptide in patients with chronic heart failure. Circ Heart Fail 2011, 4:355-360.
    • (2011) Circ Heart Fail , vol.4 , pp. 355-360
    • Miller, W.L.1    Phelps, M.A.2    Wood, C.M.3
  • 116
    • 77954357982 scopus 로고    scopus 로고
    • Processing of pro-B-type natriuretic peptide: furin and corin as candidate convertases
    • Semenov A.G., Tamm N.N., Seferian K.R., et al. Processing of pro-B-type natriuretic peptide: furin and corin as candidate convertases. Clin Chem 2010, 56:1166-1176.
    • (2010) Clin Chem , vol.56 , pp. 1166-1176
    • Semenov, A.G.1    Tamm, N.N.2    Seferian, K.R.3
  • 117
    • 79953182303 scopus 로고    scopus 로고
    • Ectodomain shedding and autocleavage of the cardiac membrane protease corin
    • Jiang J., Wu S., Wang W., et al. Ectodomain shedding and autocleavage of the cardiac membrane protease corin. J Biol Chem 2011, 286:10066-10072.
    • (2011) J Biol Chem , vol.286 , pp. 10066-10072
    • Jiang, J.1    Wu, S.2    Wang, W.3
  • 118
    • 0346732305 scopus 로고    scopus 로고
    • Functional analysis of the transmembrane domain and activation cleavage of human corin: design and characterization of a soluble corin
    • Knappe S., Wu F., Masikat M.R., Wu Q. Functional analysis of the transmembrane domain and activation cleavage of human corin: design and characterization of a soluble corin. J Biol Chem 2003, 278:52363-52370.
    • (2003) J Biol Chem , vol.278 , pp. 52363-52370
    • Knappe, S.1    Wu, F.2    Masikat, M.R.3    Wu, Q.4
  • 119
    • 77951936330 scopus 로고    scopus 로고
    • Plasma soluble corin in patients with heart failure
    • Dong N., Chen S., Yang J., et al. Plasma soluble corin in patients with heart failure. Circ Heart Fail 2010, 3:207-211.
    • (2010) Circ Heart Fail , vol.3 , pp. 207-211
    • Dong, N.1    Chen, S.2    Yang, J.3
  • 120
    • 79957775964 scopus 로고    scopus 로고
    • Human pro-B-type natriuretic peptide is processed in the circulation in a rat model
    • Semenov A.G., Seferian K.R., Tamm N.N., et al. Human pro-B-type natriuretic peptide is processed in the circulation in a rat model. Clin Chem 2011, 57:883-890.
    • (2011) Clin Chem , vol.57 , pp. 883-890
    • Semenov, A.G.1    Seferian, K.R.2    Tamm, N.N.3
  • 121
    • 79952691783 scopus 로고    scopus 로고
    • Natriuretic peptide assays revisited: do we need pro-B-type natriuretic peptide?
    • Emdin M., Passino C., Clerico A. Natriuretic peptide assays revisited: do we need pro-B-type natriuretic peptide?. J Am Coll Cardiol 2011, 57:1396-1398.
    • (2011) J Am Coll Cardiol , vol.57 , pp. 1396-1398
    • Emdin, M.1    Passino, C.2    Clerico, A.3
  • 122
    • 84884222218 scopus 로고    scopus 로고
    • Recent advances on natriuretic peptide system: new promising therapeutic targets for the treatment of heart failure
    • Del Ry S., Cabiati M., Clerico A. Recent advances on natriuretic peptide system: new promising therapeutic targets for the treatment of heart failure. Pharmacol Res 2013, 76:190-198.
    • (2013) Pharmacol Res , vol.76 , pp. 190-198
    • Del Ry, S.1    Cabiati, M.2    Clerico, A.3
  • 123
    • 12944268361 scopus 로고    scopus 로고
    • Analytical performance and diagnostic accuracy of immunometric assays for the measurement of plasma BNP and NT-proBNP concentrations
    • Clerico A., Prontera C., Emdin M., et al. Analytical performance and diagnostic accuracy of immunometric assays for the measurement of plasma BNP and NT-proBNP concentrations. Clin Chem 2005, 51:445-447.
    • (2005) Clin Chem , vol.51 , pp. 445-447
    • Clerico, A.1    Prontera, C.2    Emdin, M.3
  • 124
    • 84880984012 scopus 로고    scopus 로고
    • Systematic differences between BNP immunoassays: comparison of methods using standard protocols and quality control materials
    • Franzini M., Masotti S., Prontera C., et al. Systematic differences between BNP immunoassays: comparison of methods using standard protocols and quality control materials. Clin Chim Acta 2013, 424:287-291.
    • (2013) Clin Chim Acta , vol.424 , pp. 287-291
    • Franzini, M.1    Masotti, S.2    Prontera, C.3
  • 125
    • 63849103296 scopus 로고    scopus 로고
    • Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure
    • Niederkofler E.E., Kiernan U.A., O'Rear J., et al. Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure. Circ Heart Fail 2008, 1:258-264.
    • (2008) Circ Heart Fail , vol.1 , pp. 258-264
    • Niederkofler, E.E.1    Kiernan, U.A.2    O'Rear, J.3
  • 126
    • 28444443740 scopus 로고    scopus 로고
    • Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure
    • Hawkridge A.M., Heublein D.M., Bergen H.R., Cataliotti A., Burnett J.C., Muddiman D.C. Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure. Proc Natl Acad Sci U S A 2005, 102:17442-17447.
    • (2005) Proc Natl Acad Sci U S A , vol.102 , pp. 17442-17447
    • Hawkridge, A.M.1    Heublein, D.M.2    Bergen, H.R.3    Cataliotti, A.4    Burnett, J.C.5    Muddiman, D.C.6
  • 127
    • 84858615682 scopus 로고    scopus 로고
    • Comparison of novel pro-BNP1-108 and standard BNP assays in heart failure patients
    • Miller W.L., Grill D.E., Jaffe A.S. Comparison of novel pro-BNP1-108 and standard BNP assays in heart failure patients. Clin Chim Acta 2012, 413:920-926.
    • (2012) Clin Chim Acta , vol.413 , pp. 920-926
    • Miller, W.L.1    Grill, D.E.2    Jaffe, A.S.3
  • 128
    • 23844494143 scopus 로고    scopus 로고
    • Consensus document. Recommendations for the clinical use of cardiac natriuretic peptides
    • Emdin E., Clerico A., Clemenza F., et al. Consensus document. Recommendations for the clinical use of cardiac natriuretic peptides. J Cardiovasc Med (Ital Heart J) 2005, 6:430-446.
    • (2005) J Cardiovasc Med (Ital Heart J) , vol.6 , pp. 430-446
    • Emdin, E.1    Clerico, A.2    Clemenza, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.